RACHEL WATERS: Open Payments
NPI 1033856695 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 11 payments from 7 companies in 2025. Trend: 2023 $455 · 2024 $436 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Alkermes, Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, Auvelity, ARISTADA, Qelbree, REXULTI.
Industry payments across NY — which companies pay providers there.
